Cargando…
Federal pharmacist Paxlovid prescribing authority: A model policy or impediment to optimal care?
The U.S federal government leveraged emergency authority to allow pharmacists to prescribe Paxlovid (nirmatrelvir and ritonavir) during the COVID-19 pandemic. While heralded by pharmacy associations, the FDA framework included restrictions that arguably ran counter to clinical guidelines and evidenc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011027/ https://www.ncbi.nlm.nih.gov/pubmed/36945228 http://dx.doi.org/10.1016/j.rcsop.2023.100244 |